AK129 Combination Therapy for Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-small Cell Lung Cancer Stage IIIB/IV · Head and Neck Squamous Cell Carcinoma (HNSCC) · Colorectal Adenocarcinoma · Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Liaoning Cancer Hospital, Shenyang, Liaoning, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Taipei, Taiwan

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

NSCLC Stage IIIB · NSCLC Stage IV

Abroad (travel likely)RecruitingPHASE2

Berlin, Germany · Cologne, Germany

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Goodyear, United States · Corona, United States

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Fayetteville, United States · Fort Smith, United States